Clinical Trials Directory

Trials / Completed

CompletedNCT01890941

A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
—
Sponsor
Kissei Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
20 Years
Healthy volunteers
—

Summary

The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.

Conditions

Interventions

TypeNameDescription
DRUGKCT-0809 ophthalmic solution
DRUGPlacebo

Timeline

Primary completion
2014-03-01
First posted
2013-07-02
Last updated
2015-10-19

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01890941. Inclusion in this directory is not an endorsement.

A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes (NCT01890941) · Clinical Trials Directory